author-photo

Edward A. Kolb

Alfred I. duPont Hospital for Children

23

Papers

88

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

The B7-H3-targeting antibody-drug conjugate m276-SL-PBD is potently effective against pediatric cancer preclinical solid tumor models.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (11)
Assessment of Arsenic Trioxide and All-trans Retinoic Acid for the Treatment of Pediatric Acute Promyelocytic Leukemia: A Report From the Children's Oncology Group AAML1331 Trial.

2021 JAMA Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Second Relapse of Pediatric Patients with Acute Myeloid Leukemia: A Report on Current Treatment Strategies and Outcome of the AML-BFM Study Group

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Abstract LB-217: Preclinical evaluation of trastuzumab deruxtecan (T-DXd; DS-8201a), a HER2 antibody-drug conjugate, in pediatric solid tumors by the Pediatric Preclinical Testing Consortium (PPTC)

2020
Show All
- Source
- Cite
- Save
Citations (3)
Initial in vivo testing of a multitarget kinase inhibitor, regorafenib, by the Pediatric Preclinical Testing Consortium.

2020 Pediatric Blood & Cancer
Show All
- Source
- Cite
- Save
Citations (1)
Failures and Successes in Pediatric Patients with Acute Myeloid Leukemia with First Relapse: A Large International Report on Current Treatment Strategies and Outcome

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Revised Risk Stratification Criteria for Children with Newly Diagnosed Acute Myeloid Leukemia: A Report from the Children's Oncology Group

2017 Blood
Show All
- Source
- Cite
- Save
Citations (7)
Functional Properties of Exon 17 KIT Mutations in Pediatric CBF AML Predict for Inferior Outcome and Enhanced Response to Tyrosine Kinase Inhibition: A Report from the Children's Oncology Group

2017 Blood
Show All
- Source
- Cite
- Save
Citations (2)
Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma

2016 Oncotarget
Show All
- Source
- Cite
- Save
Citations (16)
Abstract LB-29: Disruption of annexin II tetramer/receptor axis suppresses leukemia cell homing and engraftment

2014 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)